Pradalex is an innovative third generation fluoroquinolone antibiotic for the treatment of bovine respiratory disease (BRD), only after consideration of other non-fluoroquinolones therapeutic options. Pradofloxacin, the active ingredient in Pradalex, uniquely features two modes of action.